Management of hepatitis c in kidney transplant patients: On the cusp of change

摘要

HCV infection has been a negative prognostic factor for outcomes following kidney transplantation, but with the recent approval of safe and highly efficacious interferon-free HCV therapies that yield high rates of viral clearance, patient outcomes can be expected to substantially improve. See article by Xia et al on page 2037.